CJC 1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) that does not contain the Drug Affinity Complex, designed for research applications involving acute growth hormone secretion modulation. Unlike the DAC version, this formulation has a shorter half-life, making it suitable for studying GH pulse dynamics and rapid signaling pathways. It is widely studied for its effects on GH release, IGF-1 modulation, and hypothalamic-pituitary axis regulation in controlled laboratory settings. This high-purity peptide is manufactured under strict quality control standards to ensure consistency and reliability for advanced research use only. Not for human or veterinary use.